ArticleJournal of gastrointestinal cancer2023
Evaluation of UGT1A1 and CYP3A Genotyping and Single-Point Irinotecan and Metabolite Concentrations as Predictors of the Occurrence of Adverse Events in Cancer Treatment.
Jeziel Basso et al.PubMed ↗Publisher ↗
No numbers read from the abstract.